Skip to content

Knowledge of U=U alone is unlikely to eradicate HIV stigma among gay and bisexual men in India, anthropologist argues

Annie Spratt/Unsplash

Top 5 HIV treatment stories from CROI 2022

Professor Samir Gupta (top right) presenting a study on lenacapavir at CROI 2022.

Top 5 HIV cure and vaccine stories from CROI 2022

Professor Yvonne Bryson (top centre) presenting the HIV remission case at CROI 2022.

Top 5 stories on HIV prevention from CROI 2022

Professor Raphael Landovitz (bottom left) presenting the latest data on injected PrEP at CROI 2022.

Top 5 stories on HIV, ageing and co-morbidities from CROI 2022

Professor Joel Palefsky, presenting the results of the anal screening trial, at CROI 2022. CROI 2022.

Top 5 stories on HIV treatment and care in Africa from CROI 2022

Maya Jackson-Gibson presenting the study on COVID-19 and adverse birth outcomes at CROI 2022.

Generic PrEP for young, at-risk MSM in the US could be cost-saving and health-enhancing

Image by Doctor 4U. Creative Commons licence.

Broadly neutralising antibody treatment: is pre-existing resistance its Achilles heel?

Dr Boris Juelg (bottom left) and Dr Marina Caskey (bottom right) at CROI 2022.

Why did an HIV vaccine fail in the Imbokodo trial?

Dr Glenda Gray (bottom right) at CROI 2022.